BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

November 12, 2012 7:19 AM EST
Get Alerts BMY Hot Sheet
Price: $55.74 +0.47%

Rating Summary:
    9 Buy, 13 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 12 | New: 15
Trade BMY Now!
Join SI Premium – FREE
BMO Capital downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Market Perform with a price target of $37.00 (from $38.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $32.23 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades

Related Entities

BMO Capital

Add Your Comment